Key result
A prespecified bioresorbable vascular scaffold implantation strategy was evaluated for three-year outcomes in patients with ST-segment elevation myocardial infarction.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question. A prespecified bioresorbable vascular scaffold implantation strategy was evaluated for three-year outcomes in patients with ST-segment elevation myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: